DTW Podcast: How AtriCure built a big business in Afib; A deep look into Abbott’s new Coronary imaging platform

In this week’s episode of the DeviceTalks Weekly Podcast, Dr. Nick West, CMO & divisional VP of global medical affairs at Abbott’s vascular business, discusses the European launch of the company’s new coronary imaging platform.

Dr. West explains how the AI-powered platform works and the benefits it offers for decision-making during coronary stenting procedures. He also delves into the AI-based technology behind the platform and the direction both imaging and medtech as a whole are heading with AI.

In our second interview, Mike Carrel, CEO and president of AtriCure, explains how the company became a force focusing on the atrial fibrillation (Afib) and left atrial appendage (LAA) markets.

Carrel walks listeners through the company’s efforts to expand its reach into the connected pain management market. But then he makes a strong case building out its Afib pipeline which includes the EPi-Sense System, which in April received FDA approval to treat…

Read more
  • 0

Teleflex announces $500m offering

Surgical and critical care device maker Teleflex (NYSE:TFX) announced today that it commenced a private offering of senior notes worth $500 million.

The Wayne, Pa.-based company is offering the $500 million in the form of senior notes due in 2028, with interest rate and other terms of the notes to be determined at pricing.

Each of Teleflex’s existing and future wholly-owned domestic subsidiaries that is a guarantor or other obliger under its credit agreement will be guaranteeing the notes, according to a news release.

Teleflex said in the release that it plans to use the net proceeds collected in the offering to repay borrowings under its revolving credit facility.

Read more
  • 0